New comment by at Mayo Clinic College of Medicine ( January 28, 2021)
I totally concur with the comments by Dr. @Eli Miloslavsky. In clinical practice, the treatment of ANCA associated vasculitis with a combination therapy of cyclophosphamide (C...
New answer by at The Ohio State University (May 3, 2024)
Circling back to this now that we have more data. I agree with Dr. @Quiceno's main conclusion that GN or the presence of concomitant anti-GBM antibodies are the primary scenar...
This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeeting. This question was inspi...
New answer by at Massachusetts General Hospital (November 27, 2024)
This is an important question. Currently there are several groups of patients that benefit from reduced dose glucocorticoids:
The largest group are patients who are receiving...